These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36180404)

  • 1. Development of chemiluminescent lab-on-fiber immunosensors for rapid point-of-care testing of anti-SARS-CoV-2 antibodies and evaluation of longitudinal immune response kinetics following three-dose inactivation virus vaccination.
    Xu W; Song D; Liu J; Han X; Xu J; Zhu A; Long F
    J Med Virol; 2023 Jan; 95(1):e28190. PubMed ID: 36180404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, label-free, and sensitive point-of-care testing of anti-SARS-CoV-2 IgM/IgG using all-fiber Fresnel reflection microfluidic biosensor.
    Xu W; Liu J; Song D; Li C; Zhu A; Long F
    Mikrochim Acta; 2021 Jul; 188(8):261. PubMed ID: 34278534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPEEDS: A portable serological testing platform for rapid electrochemical detection of SARS-CoV-2 antibodies.
    Peng R; Pan Y; Li Z; Qin Z; Rini JM; Liu X
    Biosens Bioelectron; 2022 Feb; 197():113762. PubMed ID: 34773750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
    J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
    Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
    Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon Nanostructured Immunosensing of Anti-SARS-CoV-2 S-Protein Antibodies.
    du Plooy J; Kock B; Jahed N; Iwuoha E; Pokpas K
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.
    Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X
    Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical Immunosensors Based on Zinc Oxide Nanorods for Detection of Antibodies Against SARS-CoV-2 Spike Protein in Convalescent and Vaccinated Individuals.
    Nunez FA; Castro ACH; de Oliveira VL; Lima AC; Oliveira JR; de Medeiros GX; Sasahara GL; Santos KS; Lanfredi AJC; Alves WA
    ACS Biomater Sci Eng; 2023 Jan; 9(1):458-473. PubMed ID: 36048716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new testing platform using fingerstick blood for quantitative antibody response evaluation after SARS-CoV-2 vaccination.
    Du J; Zhang D; Pathakamuri JA; Kuebler D; Yang Y; Loginova Y; Chu E; Madej R; Neves JV; Singer B; Radke H; Spencer N; Rizk E; Zhang A; Lu CM; Sha MY
    Emerg Microbes Infect; 2022 Dec; 11(1):250-259. PubMed ID: 34951566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.
    Barreira GA; Santos EHD; Pereira MFB; Rodrigues KA; Rocha MC; Kanunfre KA; Marques HHS; Okay TS; ; Eisencraft AP; Rossi Junior A; Fante AL; Cora AP; Costa Reis AGA; Ferrer APS; Andrade APM; Watanabe A; Gonçalves AMF; Waetge ARP; Silva CA; Ceneviva C; Lazari CDS; Abellan DM; Sabino EC; Bianchini FRM; Alcantara FFP; Ramos GF; Leal GN; Rodriguez IS; Pinho JRR; Carneiro JDA; Paz JA; Ferreira JC; Ferranti JF; Ferreira JOA; Framil JVS; Silva KRD; Bastos KLM; Galleti KV; Cristofani LM; Suzuki L; Campos LMA; Perondi MBM; Diniz MFR; Fonseca MFM; Cordon MNA; Pissolato M; Peres MS; Garanito MP; Imamura M; Dorna MB; Luglio M; Aikawa NE; Degaspare NV; Sakita NK; Udsen NL; Scudeller PG; Gaiolla PVV; Severini RDSG; Rodrigues RM; Toma RK; Paula RIC; Palmeira P; Forsait S; Farhat SCL; Sakano TMS; Koch VHK; Cobello Junior V
    Rev Inst Med Trop Sao Paulo; 2022; 64():e49. PubMed ID: 35858039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
    Hayer J; Urlaub E
    Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
    Kobashi Y; Shimazu Y; Kawamura T; Nishikawa Y; Omata F; Kaneko Y; Kodama T; Tsubokura M
    PLoS One; 2022; 17(6):e0269917. PubMed ID: 35687563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
    Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
    BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S
    J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Lateral Flow Immunoassay COVIDTECH
    Exinger J; Hartard C; Lafferrière F; Fenninger C; Charbonnière LJ; Jeulin H
    Jpn J Infect Dis; 2022 Jul; 75(4):334-340. PubMed ID: 34980703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic observation of SARS-CoV-2 IgM, IgG, and neutralizing antibodies in the development of population immunity through COVID-19 vaccination.
    Jiang R; Dou X; Li M; Wang E; Hu J; Xiong D; Zhang X
    J Clin Lab Anal; 2022 Apr; 36(4):e24325. PubMed ID: 35235705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.